Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LivaloVA in Dyslipidemia and Hypertension
NCT05331014Phase 3Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Nov 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pitavastatin, valsartan in dyslipidemia, hypertension (HTN), sponsored by JW Pharmaceutical Corporation. Started Nov 2021; status: completed.
02
Drugs
pitavastatinvalsartan
03
Conditions
dyslipidemiahypertension (HTN)
Beyond the preview
Go deeper on NCT05331014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05331014.